- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Zydus Lifesciences Limited has announced a board meeting to discuss the acquisition of an 85.6% controlling stake in Amplitude Surgical SA, France. The acquisition will be executed through Put Option Agreements and Share Purchase Agreements, with a total consideration of approximately €256.8 million, at a price of €6.25 per share. Following the completion, Zydus will initiate a mandatory simplified cash tender offer for the remaining shares, aiming for a full acquisition and subsequent delisting of Amplitude. This strategic move positions Zydus to strengthen its presence in the global MedTech market, leveraging Amplitude's established market footprint.